These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 1287460

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [An experimental study on shock after temporary hepatic inflow occlusion and platelet activating factor (PAF)].
    Fukuoka T.
    Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1596-602. PubMed ID: 2263243
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protective effect of platelet-activating factor antagonist on hepatic energy metabolism following transient hepatic inflow occlusion in rabbits.
    Takada Y, Shimahara Y, Yamaguchi T, Nishizawa F, Mori K, Yamaoka Y, Ozawa K.
    Circ Shock; 1992 Oct; 38(2):130-7. PubMed ID: 1423921
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Involvement of platelet activating factors in pathologic leukocyte-endothelium interactions in the liver after hemorrhagic shock].
    Marzi I, Bauer M, Reisdorf E, Walcher F.
    Zentralbl Chir; 1994 Oct; 119(11):814-21. PubMed ID: 7846961
    [Abstract] [Full Text] [Related]

  • 7. Rat liver blood flow after ischemia and reperfusion. The effects of the platelet-activating factor antagonist WEB-2170 and of removing circulating leukocytes.
    Chávez-Cartaya RE, Metcalfe S, Ramirez-Romero P, Calne R, Jamieson NV.
    Transplantation; 1994 May 27; 57(10):1440-4. PubMed ID: 8197604
    [Abstract] [Full Text] [Related]

  • 8. Induction of tissue injury and altered cardiovascular performance by platelet-activating factor: relevance to multiple systems organ failure.
    Lefer AM.
    Crit Care Clin; 1989 Apr 27; 5(2):331-52. PubMed ID: 2650821
    [Abstract] [Full Text] [Related]

  • 9. Protective effect of platelet-activating factor antagonist on ischemia-induced liver injury in rats.
    Wang KS, Monden M, Kanai T, Gotoh M, Umeshita K, Ukei T, Mori T.
    Surgery; 1993 Jan 27; 113(1):76-83. PubMed ID: 8417492
    [Abstract] [Full Text] [Related]

  • 10. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B, Squadrito F, Bussolino F, Calapai G, Altavilla D, Ioculano M, Campo GM, Canale P, Caputi AP.
    J Lipid Mediat Cell Signal; 1994 Mar 27; 9(2):123-34. PubMed ID: 8012759
    [Abstract] [Full Text] [Related]

  • 11. Deleterious effects of splanchnic congestion on hepatic energy metabolism following repeated portal triad cross-clamping in dogs.
    Yamamoto S, Nitta N, Ozaki N, Morimoto T, Kamiyama Y, Yamaoka Y, Okanoue T, Ozawa K.
    Circ Shock; 1988 Oct 27; 26(2):193-201. PubMed ID: 3197265
    [Abstract] [Full Text] [Related]

  • 12. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart.
    Loucks EB, Godin DV, Walley KR, McManus BM, Rahimian R, Granville DJ, Hong JM, Aktary FM, Qayumi AK.
    Can J Cardiol; 2003 Mar 15; 19(3):267-74. PubMed ID: 12677282
    [Abstract] [Full Text] [Related]

  • 13. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD, Mikulaschek AW.
    Circ Shock; 1986 Mar 15; 20(3):193-203. PubMed ID: 3802423
    [Abstract] [Full Text] [Related]

  • 14. The effects of a bradykinin B2 receptor antagonist in extended liver resection with ischemia in dogs.
    Totsuka O, Takeyoshi I, Tsutsumi H, Hashimoto N, Sunose Y, Tokumine M, Ohwada S, Matsumoto K, Morishita Y.
    Hepatogastroenterology; 2004 Mar 15; 51(60):1771-5. PubMed ID: 15532823
    [Abstract] [Full Text] [Related]

  • 15. Role of platelet activating factor in development of thrombocytopenia and neutropenia in dogs with endotoxemia.
    Tsuchiya R, Kyotani K, Scott MA, Nishizono K, Ashida Y, Mochizuki T, Kitao S, Yamada T, Kobayashi K.
    Am J Vet Res; 1999 Feb 15; 60(2):216-21. PubMed ID: 10048555
    [Abstract] [Full Text] [Related]

  • 16. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
    Doebber TW, Wu MS, Biftu T.
    J Immunol; 1986 Jun 15; 136(12):4659-68. PubMed ID: 3011900
    [Abstract] [Full Text] [Related]

  • 17. FR128998 ameliorates liver injury in extended liver resection with ischemia in dogs.
    Iwazaki S, Takeyoshi I, Ohwada S, Sunose Y, Tsutsumi H, Kawashima Y, Matsumoto K, Morishita Y.
    Hepatogastroenterology; 2001 Jun 15; 48(37):197-202. PubMed ID: 11268964
    [Abstract] [Full Text] [Related]

  • 18. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis.
    Felix SB, Baumann G, Hashemi T, Niemczyk M, Ahmad Z, Berdel WE.
    J Cardiovasc Pharmacol; 1990 Jun 15; 15(6):987-97. PubMed ID: 1694923
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
    Nagaoka J, Harada K, Kimura A, Kobayashi S, Murakami M, Yoshimura T, Yamada K, Asano O, Katayama K, Yamatsu I.
    Arzneimittelforschung; 1991 Jul 15; 41(7):719-24. PubMed ID: 1663352
    [Abstract] [Full Text] [Related]

  • 20. Protecting the viability of hepatic allografts procured from non-heart-beating donors by blockade of endothelin and platelet activating factor in porcine liver transplantation.
    Fukunaga K, Takada Y, Taniguchi H, Yuzawa K, Otsuka M, Todoroki T, Goto K, Fukao K.
    Int Surg; 1998 Jul 15; 83(3):226-31. PubMed ID: 9870780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.